‘Groundbreaking’ anti-aging drug for dogs moves closer to gaining FDA approval. By Bing AI
Carly Cassella -- ScienceAlert
Dec. 2, 2023
A new drug is currently in the works that could one day extend the lifespan of some large canine breeds.
The medicine has been developed by the veterinary biotech company, Loyal for Dogs, and while it still needs to undergo clinical trials, officials at the United States Food and Drug Administration (FDA) have said in a letter to the company that its initial data is "sufficient" to show "a reasonable expectation of effectiveness," according to a copy of the letter supplied to The New York Times.
LOY-001 is the name of the first version of the drug, which is targeted at dogs 7 years of age and older, weighing at least 40 pounds (18 kilograms). It comes as an injection that can be given to dogs every three to six months by vets.
At the same time, scientists at Loyal are also working on two other versions, called LOY-002 and LOY-003, which would be taken as daily pills. LOY-003 is designed for all older dogs except for the smallest breeds.
(more)
READ MORE: ScienceAlert